BP Marsh ups stake in Pantheon Specialty Group to 41pc.


BP Marsh announced on Thursday that it had increased its stake in Pantheon Specialty Group to 41% after acquiring an additional 2% holding based on a £275m equity valuation.

  • B.P. Marsh & Partners
  • 02 April 2026 11:59:22
BP Marsh & Partners

Source: Sharecast

The AIM-traded group said the shares were purchased from Pantheon’s founders, Robert Dowman and Michael Lee, and funded from existing cash reserves.

BP Marsh first invested in the business in June 2023 with a 25% stake and had since made incremental investments to build its position.

Pantheon, a London market wholesale insurance broker focused on specialty lines, had expanded from its original global casualty and professional lines offering into areas including marine, global property, innovation and technology, and delegated authorities.

The company said it had established a diversified, multi-division platform supported by senior hires and strengthened relationships with brokers, managing general agents and carriers.

“BP Marsh's continued support is a strong endorsement of Pantheon's development since launch,” said Robert Dowman, founder and chief executive of Pantheon.

“We have made significant progress in building a diversified specialty broking platform, broadening our capabilities and attracting a high-quality team, which together have driven our growth and performance.

“With strong foundations in place and clear momentum across the business, we remain focused on scaling the platform and delivering long-term value for our clients and partners.”

Financially, Pantheon had delivered strong growth, with revenue increasing from around £23.8m in the 2025 financial year to approaching £30m in 2026, while profit before tax was expected to exceed £15m.

The business had also reportedly maintained strong EBITDA margins and cash generation, reflecting what BP Marsh described as a scalable and capital-light model.

“We are very pleased to further increase our investment in Pantheon and to continue backing the business,” commented Dan Topping, chief executive of BP Marsh and a nominee director on Pantheon’s board.

“Since our initial investment, Pantheon has delivered excellent progress, combining strong financial performance with the successful execution of its growth strategy.

“The business has rapidly scaled its platform, expanded its product offering and demonstrated the strength of its earnings model.

“We have strong confidence in Pantheon's long-term potential and look forward to supporting the business as it continues to scale.”

At 1009 BST, shares in BP Marsh & Partners were down 0.76% at 650p.

Reporting by Josh White for Sharecast.com.

See latest RNS on Investegate


N/A

ISIN: N/A
Exchange: N/A
Sell:
N/A
Buy:
N/A
Change:
Date:
Prices delayed by at least 15 minutes

Compare our accounts

If you're looking to grow your money over the longer term (5+ years), we have a range of investment choices to help.

Halifax is not responsible for the content and accuracy of the Markets News articles. We may not share the views of the author. Understand the risks, please remember the value of your investment can go down as well as up and you may not get back the full amount you invest. We don't provide advice so if you are in any doubt about buying and selling shares or making your own investment decisions we recommend you seek advice from a suitably qualified Financial Advisor. Past performance is not a guide to future performance.